Compensation Agreements in the Biotechnology Industry

1,144 Contracts & Agreements

Browse by Company

2seventy bio, Inc. (1 contract)
4D Molecular Therapeutics Inc (1)
89bio, Inc. (3)
AbbVie Inc. (3)
ACADIA PHARMACEUTICALS INC (5)
Acorda Therapeutics (1)
Acumen Pharmaceuticals, Inc. (2)
Adagio Therapeutics, Inc. (2)
Adamas Pharmaceuticals Inc (4)
ADMA BIOLOGICS, INC. (1)
ADURO BIOTECH, INC. (4)
Adverum Biotechnologies, Inc. (6)
Aerovate Therapeutics, Inc. (2)
AGENUS INC (4)
AgeX Therapeutics, Inc. (1)
Aimmune Therapeutics, Inc. (2)
AKCEA THERAPEUTICS, INC. (3)
Akebia Therapeutics, Inc. (5)
Akero Therapeutics, Inc. (3)
Akouos, Inc. (1)
ALBIREO PHARMA, INC. (11)
Alector, Inc. (2)
Alexion Pharmaceuticals (1)
Aligos Therapeutics, Inc. (1)
Allakos Inc. (5)
Allena Pharmaceuticals, Inc. (4)
Allogene Therapeutics, Inc. (3)
ALNYLAM PHARMACEUTICALS, INC. (2)
ALPINE IMMUNE SCIENCES, INC. (4)
Altimmune, Inc. (2)
ALX ONCOLOGY HOLDINGS INC (2)
AMARILLO BIOSCIENCES INC (1)
AMARIN CORP PLC (1)
Amgen Inc. (13)
Amplitude Healthcare Acquisition Corp (2)
Anchiano Therapeutics Ltd. (1)
Anika Therapeutics (1)
Annexon, Inc. (4)
Apellis Pharmaceuticals, Inc. (3)
Applied Molecular Transport Inc. (1)
Aptinyx Inc. (3)
Aravive, Inc. (3)
Arcellx, Inc. (1)
Arcus Biosciences, Inc. (6)
Arcutis Biotherapeutics, Inc. (1)
ARDELYX, INC. (3)
ARENA PHARMACEUTICALS INC (14)
ARROWHEAD PHARMACEUTICALS, INC. (1)
Arsanis, Inc. (1)
Artiva Biotherapeutics, Inc. (1)
ARYA Sciences Acquisition Corp II (5)
Atreca, Inc. (1)
Aura Biosciences, Inc. (1)
Avid Bioservices, Inc. (1)
Avidity Biosciences, Inc. (4)
Avita Therapeutics, Inc. (1)
Axovant Sciences Ltd. (2)
Ayala Pharmaceuticals, Inc. (1)
AZIYO BIOLOGICS, INC. (1)
BCTG Acquisition Corp. (3)
Beam Therapeutics Inc. (4)
BeiGene, Ltd. (6)
BELLICUM PHARMACEUTICALS, INC (8)
BICYCLE THERAPEUTICS Ltd (4)
BioAtla, Inc. (1)
BIOCEPT INC (1)
BIOMARIN PHARMACEUTICAL INC (9)
Biomea Fusion, Inc. (1)
Biostage, Inc. (2)
BioXcel Therapeutics, Inc. (1)
Black Diamond Therapeutics, Inc. (2)
bluebird bio, Inc. (1)
Bone Biologics Corp (1)
BRAINSTORM CELL THERAPEUTICS INC. (6)
BriaCell Therapeutics Corp. (2)
BridgeBio Pharma, Inc. (2)
BullFrog AI Holdings, Inc. (1)
Cabaletta Bio, Inc. (3)
CALADRIUS BIOSCIENCES, INC. (9)
Calyxt, Inc. (1)
CAPRICOR THERAPEUTICS, INC. (1)
CareDx, Inc. (5)
Caribou Biosciences, Inc. (12)
CASTLE BIOSCIENCES INC (7)
CATABASIS PHARMACEUTICALS INC (2)
CATALYST BIOSCIENCES, INC. (3)
Cellectar Biosciences, Inc. (1)
Cellular Biomedicine Group, Inc. (1)
Checkmate Pharmaceuticals, Inc. (1)
Checkpoint Therapeutics, Inc. (2)
Chelsea Worldwide Inc. (1)
ChemoCentryx, Inc. (7)
CHIMERIX INC (6)
Cidara Therapeutics, Inc. (3)
CLEVELAND BIOLABS INC (2)
Codiak BioSciences, Inc. (2)
CohBar, Inc. (1)
Conatus Pharmaceuticals Inc. (3)
CONCERT PHARMACEUTICALS, INC. (8)
Constellation Alpha Capital Corp. (2)
CONSTELLATION PHARMACEUTICALS INC (1)
CONTRAFECT Corp (2)
Corbus Pharmaceuticals Holdings, Inc. (1)
Cortexyme, Inc. (1)
Crinetics Pharmaceuticals, Inc. (2)
CTI BIOPHARMA CORP (12)
Cue Biopharma, Inc. (2)
Cullinan Oncology, LLC (2)
CURIS INC (6)
Cyclerion Therapeutics, Inc. (2)
CytoDyn Inc. (4)
Cytokinetics, Incorporated (6)
CYTORI THERAPEUTICS, INC. (1)
Deciphera Pharmaceuticals, Inc. (3)
Denali Therapeutics Inc. (4)
Design Therapeutics, Inc. (1)
Dynamics Special Purpose Corp. (1)
DYNAVAX TECHNOLOGIES CORP (7)
Eagle Pharmaceuticals, Inc. (1)
Editas Medicine, Inc. (2)
Eidos Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (6)
Emergent BioSolutions Inc. (3)
Entasis Therapeutics Holdings Inc. (4)
Entrada Therapeutics, Inc. (2)
ENZON PHARMACEUTICALS, INC. (6)
Epizyme, Inc. (5)
Equillium, Inc. (6)
Erasca, Inc. (1)
Esperion Therapeutics, Inc. (2)
Evelo Biosciences, Inc. (4)
EXACT SCIENCES CORP (16)
Exelixis (34)
FATE THERAPEUTICS INC (6)
FIBROGEN INC (7)
FIVE PRIME THERAPEUTICS INC (1)
Flex Pharma, Inc. (3)
Flexion Therapeutics Inc (7)
Forma Therapeutics Holdings, Inc., (4)
Frequency Therapeutics, Inc. (1)
G1 Therapeutics, Inc. (4)
Galecto Inc. (3)
Galera Therapeutics, Inc. (4)
Gemphire Therapeutics Inc. (2)
GENELUX CORP (1)
Generation Bio Co. (2)
GENEREX BIOTECHNOLOGY CORP (3)
Genprex, Inc. (3)
GeoVax Labs, Inc. (2)
GERON CORP (10)
Gilead Sciences (4)
Global Blood Therapeutics, Inc. (4)
GLYCOMIMETICS INC (5)
Gossamer Bio, Inc. (4)
Graphite Bio, Inc. (1)
Gritstone Oncology, Inc. (1)
GTX INC (24)
GX Acquisition Corp. (1)
HALOZYME THERAPEUTICS INC (2)
HARBOR DIVERSIFIED, INC. (1)
Harpoon Therapeutics, Inc. (3)
HCW Biologics Inc. (1)
HilleVax, Inc. (2)
HISTOGENICS CORP (2)
Homology Medicines, Inc. (3)
HUMANIGEN, INC (2)
Icosavax, Inc. (1)
IDEAYA Biosciences, Inc. (1)
IDERA PHARMACEUTICALS, INC. (6)
IGM Biosciences, Inc. (5)
Imago BioSciences, Inc. (2)
IMMUCELL CORP (1)
Immuneering Corp (2)
ImmunoCellular Therapeutics, Ltd. (2)
IMMUNOGEN INC (10)
Immunome Inc. (3)
IN8BIO, INC. (2)
Inhibrx, Inc. (1)
Inozyme Pharma, Inc. (1)
Inspyr Therapeutics, Inc. (5)
Intec Parent Inc. (1)
Intec Pharma Ltd. (2)
Intellia Therapeutics, Inc. (3)
INTERCEPT PHARMACEUTICALS, INC. (4)
INTREXON CORP (1)
Intrinsic Medicine, Inc. (1)
IONIS PHARMACEUTICALS INC (3)
IOVANCE BIOTHERAPEUTICS, INC. (1)
IRONWOOD PHARMACEUTICALS INC (4)
Janux Therapeutics, Inc. (1)
Jounce Therapeutics, Inc. (7)
KalVista Pharmaceuticals, Inc. (2)
Karyopharm Therapeutics Inc. (2)
Keros Therapeutics, Inc. (1)
Kezar Life Sciences, Inc. (3)
Kiniksa Pharmaceuticals, Ltd. (2)
Kinnate Biopharma Inc. (2)
Kodiak Sciences Inc. (2)
Kronos Bio, Inc. (3)
Kura Oncology, Inc. (4)
Kymera Therapeutics, Inc. (2)
Leisure Acquisition Corp. (1)
LEXICON PHARMACEUTICALS, INC. (11)
LianBio (1)
Ligand Pharmaceuticals Incorporated (1)
Locust Walk Acquisition Corp. (4)
Lyell Immunopharma, Inc. (1)
MADRIGAL PHARMACEUTICALS, INC. (6)
MANNKIND CORP (3)
MATEON THERAPEUTICS INC (7)
Matinas BioPharma Holdings, Inc. (2)
MEI Pharma, Inc. (1)
MeiraGTx Holdings plc (6)
MERRIMACK PHARMACEUTICALS INC (1)
Mersana Therapeutics, Inc. (1)
Merus N.V. (2)
Metacrine, Inc. (3)
Millendo Therapeutics, Inc. (5)
MiMedx Group, Inc. (7)
Minerva Neurosciences, Inc. (2)
MIRAGEN THERAPEUTICS, INC. (1)
Mirati Therapeutics, Inc. (9)
Mirum Pharmaceuticals, Inc. (1)
Moderna, Inc. (4)
Molecular Templates, Inc. (4)
Momenta Pharmaceuticals, Inc. (13)
Myovant Sciences Ltd. (4)
Myriad Genetics, Inc. (12)
NantKwest, Inc. (1)
Natera, Inc. (6)
NEUROTROPE BIOSCIENCE, INC. (2)
Neurotrope, Inc. (1)
NexImmune, Inc. (2)
NextCure, Inc. (2)
Nkarta, Inc. (4)
NORTHWEST BIOTHERAPEUTICS INC (1)
NTN BUZZTIME INC (2)
Nuvalent, Inc. (2)
Ohr Pharmaceutical Inc (3)
Olema Pharmaceuticals, Inc. (2)
Omega Therapeutics, Inc. (1)
OPGEN INC (3)
Ophthotech Corp. (4)
Oric Pharmaceuticals, Inc. (2)
Outlook Therapeutics, Inc. (1)
Ovid Therapeutics Inc. (3)
Oyster Point Pharma, Inc. (2)
PDL BIOPHARMA, INC. (1)
PepGen Inc. (2)
PharmaCyte Biotech, Inc. (4)
PhaseBio Pharmaceuticals Inc (5)
PIERIS PHARMACEUTICALS, INC. (7)
PLURISTEM THERAPEUTICS INC (3)
PMV Pharmaceuticals, Inc. (3)
POLARITYTE, INC. (3)
PORTOLA PHARMACEUTICALS INC (7)
Poseida Therapeutics, Inc. (3)
Praxis Precision Medicines, Inc. (2)
PRECISION BIOSCIENCES INC (3)
Prevail Therapeutics Inc. (2)
Progenics Pharmaceuticals, Inc. (2)
Prometheus Biosciences, Inc. (2)
Protagenic Therapeutics, Inc. (1)
PROTEON THERAPEUTICS INC (4)
PROTEOSTASIS THERAPEUTICS, INC. (2)
PUMA BIOTECHNOLOGY, INC. (6)
Radius Health, Inc. (4)
RAPT Therapeutics, Inc. (4)
RECURSION PHARMACEUTICALS, INC. (1)
REGENXBIO Inc. (6)
Regulus Therapeutics Inc. (6)
Relay Therapeutics, Inc. (3)
Reneo Pharmaceuticals, Inc. (2)
RenovoRx, Inc. (4)
Replimune Group, Inc. (1)
Retrophin, Inc. (3)
Revolution Medicines, Inc. (4)
REXAHN PHARMACEUTICALS, INC. (3)
RHYTHM PHARMACEUTICALS, INC. (7)
RIGEL PHARMACEUTICALS INC (4)
RITTER PHARMACEUTICALS INC (1)
Rubius Therapeutics, Inc. (1)
Sage Therapeutics, Inc. (5)
Sana Biotechnology, Inc. (3)
Sarepta Therapeutics, Inc. (1)
Savara Inc (2)
SEATTLE GENETICS INC (2)
SELECTA BIOSCIENCES INC (6)
Sensei Biotherapeutics, Inc. (2)
SERA PROGNOSTICS, INC. (1)
Seres Therapeutics, Inc. (6)
Shattuck Labs, Inc. (1)
Shuttle Pharmaceuticals Holdings, Inc. (1)
Sigilon Therapeutics, Inc. (2)
Silverback Therapeutics, Inc. (2)
Solid Biosciences Inc. (7)
SOPHIRIS BIO INC. (1)
Sorrento Therapeutics, Inc. (2)
Spero Therapeutics, Inc. (3)
SPHERIX INC (6)
Spring Bank Pharmaceuticals, Inc. (4)
SpringWorks Therapeutics, Inc. (3)
SPRUCE BIOSCIENCES, INC. (4)
SQZ Biotechnologies Co (2)
Stellar Biotechnologies, Inc. (1)
SUNESIS PHARMACEUTICALS INC (7)
Syndax Pharmaceuticals Inc (2)
SYNLOGIC, INC. (4)
Syros Pharmaceuticals, Inc. (1)
T2 Biosystems, Inc. (10)
Talaris Therapeutics, Inc. (2)
Taysha Gene Therapies, Inc. (2)
TENAX THERAPEUTICS, INC. (3)
Tenaya Therapeutics, Inc. (1)
TG THERAPEUTICS, INC. (1)
Tocagen Inc (4)
Tracon Pharmaceuticals, Inc. (7)
Translate Bio, Inc. (3)
TREVENA INC (4)
Turning Point Therapeutics, Inc. (4)
Tyra Biosciences, Inc. (1)
U.S. Stem Cell, Inc. (3)
Ultragenyx Pharmaceutical Inc. (2)
Unity Biotechnology, Inc. (5)
Unum Therapeutics Inc. (3)
UroGen Pharma Ltd. (1)
VACCINEX, INC. (1)
Vaxart, Inc. (1)
Vera Therapeutics, Inc. (1)
Vericel Corp (4)
Vertex Pharmaceuticals Inc (15)
Verve Therapeutics, Inc. (2)
VICAL INC (3)
Viela Bio, Inc. (2)
Vigil Neuroscience, Inc. (1)
Viking Therapeutics, Inc. (4)
Vir Biotechnology, Inc. (3)
VITAL THERAPIES INC (4)
Vor Biopharma Inc. (1)
Xencor Inc (8)
Xilio Therapeutics, Inc. (2)
Y-mAbs Therapeutics, Inc. (1)
Zai Lab Ltd (3)
Zentalis Pharmaceuticals, LLC (4)

Recent Contracts

Second Amended and Restated Non-Employee Director Compensation Program, effective June 6, 2023 (Akebia Therapeutics, Inc., Filed With SEC on August 28, 2023)
Amended and Restated Non-employee director compensation policy (Taysha Gene Therapies, Inc., Filed With SEC on August 14, 2023)
Non-Employee Director Compensation Program (HilleVax, Inc., Filed With SEC on August 14, 2023)
Compensation Recovery Policy (Aerovate Therapeutics, Inc., Filed With SEC on August 14, 2023)
Amended and Restated Non-Employee Directors Compensation Plan (Checkpoint Therapeutics, Inc., Filed With SEC on August 14, 2023)
Amended and Restated Outside Director Compensation Policy (SUNESIS PHARMACEUTICALS INC, Filed With SEC on August 14, 2023)
Amended and Restated Non-Employee Director Compensation Policy (Xilio Therapeutics, Inc., Filed With SEC on August 14, 2023)
Amended and Restated Non-Employee Director Compensation Policy (RAPT Therapeutics, Inc., Filed With SEC on August 11, 2023)
Non-Employee Director Compensation Policy (Cullinan Oncology, LLC, Filed With SEC on August 10, 2023)
Non-Employee Director Compensation Program (MeiraGTx Holdings plc, Filed With SEC on August 10, 2023)
Second Amended and Restated Non-Employee Director Compensation Policy (Cabaletta Bio, Inc., Filed With SEC on August 10, 2023)
Amended and Restated Non-Employee Director Compensation Policy (Kura Oncology, Inc., Filed With SEC on August 9, 2023)
Outside Director Compensation Policy (Allakos Inc., Filed With SEC on August 9, 2023)
Amended and Restated Non-Employee Director Compensation Policy, effective as of June 1, 2023 (Relay Therapeutics, Inc., Filed With SEC on August 8, 2023)
Amended and Restated Non-Employee Director Compensation Policy (FATE THERAPEUTICS INC, Filed With SEC on August 8, 2023)
Non-Employee Director Compensation Policy, as amended on April 28, 2023 (PepGen Inc., Filed With SEC on August 8, 2023)
Non-Employee Director Compensation Policy, Amended and Restated June 22, 2023 (Mirati Therapeutics, Inc., Filed With SEC on August 8, 2023)
Non-Employee Director Compensation Program (Annexon, Inc., Filed With SEC on August 7, 2023)
Sigilon Therapeutics, Inc. Non-Employee Director Compensation Policy, as amended on May 23, 2023 (Sigilon Therapeutics, Inc., Filed With SEC on August 7, 2023)
Non-Employee Director Compensation Policy (BCTG Acquisition Corp., Filed With SEC on August 7, 2023)
Amended Compensation Program for Non-Employee Directors (Natera, Inc., Filed With SEC on August 4, 2023)
Non-Employee Director Compensation Policy (Myriad Genetics, Inc., Filed With SEC on August 4, 2023)
Immuneering Corporation Non-Employee Director Compensation Program, as amended, effective (Immuneering Corp, Filed With SEC on August 3, 2023)
Vericel Corporation Deferred Compensation Plan (Vericel Corp, Filed With SEC on August 2, 2023)
Non-Employee Director Compensation Policy, as amended (ARYA Sciences Acquisition Corp II, Filed With SEC on August 2, 2023)
Non-Employee Director Compensation Policy (AMARIN CORP PLC, Filed With SEC on August 2, 2023)
Amended and Restated Non-Employee Director Compensation Policy (GLYCOMIMETICS INC, Filed With SEC on August 2, 2023)
G1 Therapeutics, Inc. Deferred Compensation Plan for Non-Employee Directors (G1 Therapeutics, Inc., Filed With SEC on August 2, 2023)
Compensation Policy for Non-Employee Directors, as amended through June 14, 2023 (IMMUNOGEN INC, Filed With SEC on July 31, 2023)
Avid Bioservices, Inc. Deferred Compensation Plan (Avid Bioservices, Inc., Filed With SEC on July 13, 2023)
Amended and Restated Non-Employee Director Compensation Policy (Gemphire Therapeutics Inc., Filed With SEC on June 29, 2023)
Amended and Restated Outside Director Compensation Policy (Genprex, Inc., Filed With SEC on June 27, 2023)
Non-Employee Director Compensation Program (Arcus Biosciences, Inc., Filed With SEC on June 16, 2023)
Amended and Restated MEI Pharma, Inc. 2021 Inducement Grant Equity Compensation Plan (MEI Pharma, Inc., Filed With SEC on June 13, 2023)
Non-Employee Director Compensation Policy (REXAHN PHARMACEUTICALS, INC., Filed With SEC on May 15, 2023)
Non-Employee Director Compensation Policy, as amended on March 30, 2023 (SPRUCE BIOSCIENCES, INC., Filed With SEC on May 15, 2023)
Amended and Restated Non-Employee Director Compensation Policy (NEUROTROPE BIOSCIENCE, INC., Filed With SEC on May 15, 2023)
Non-Employee Director Compensation Program (CONTRAFECT Corp, Filed With SEC on May 15, 2023)
Non-Qualified Deferred Compensation Plan (Avita Therapeutics, Inc., Filed With SEC on May 11, 2023)
Nkarta, Inc. Non-Employee Director Compensation Policy, as amended on March 22, 2023 (Nkarta, Inc., Filed With SEC on May 11, 2023)